Neogenomics (NEO) Acquisitions (2014 - 2025)

Neogenomics (NEO) reported Acquisitions of $463000.0 for Q3 2025, down 99.89% quarter-over-quarter from $419.4 million in Q2 2021.

Neogenomics (NEO) Acquisitions (2014 - 2025) Analysis & Trends

Neogenomics has reported Acquisitions for 4 years, with the latest figure at $463000.0 in Q3 2025.

For the quarter ending Q3 2025, Acquisitions changed N/A year-over-year to $463000.0; the trailing twelve-month figure through Dec 2025 stood at $463000.0 (changed N/A YoY), and the FY2025 full-year result was $6.5 million, changed N/A from the prior year.
Acquisitions for Q3 2025 stood at $463000.0, down from $419.4 million in the prior quarter.
The five-year high for Acquisitions was $419.4 million in Q2 2021, with the low at $463000.0 in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Acquisitions (Qtr)
1	Waters	30,529.42 Bn	30,528.96 Bn	1.11 Bn	144.00 Mn
2	Thermo Fisher Scientific	183.75 Bn	180.50 Bn	7.74 Bn	8.87 Bn
3	Danaher	133.13 Bn	127.43 Bn	3.59 Bn	-
4	Idexx Laboratories	46.14 Bn	45.94 Bn	722.74 Mn	-
5	Agilent Technologies	38.20 Bn	36.39 Bn	990.00 Mn	-
6	Natera	31.50 Bn	30.40 Bn	696.04 Mn	-
7	Iqvia Holdings	31.34 Bn	29.36 Bn	1.36 Bn	37.00 Mn
8	Illumina	24.51 Bn	23.36 Bn	721.00 Mn	415.00 Mn
9	Mettler Toledo International	23.53 Bn	23.47 Bn	555.82 Mn	2.24 Mn
10	Neogenomics	1.48 Bn	1.33 Bn	80.86 Mn	-

Download Data